Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Jun 10, 2020 6:44pm
80 Views
Post# 31136019

RE:RE:RE:Nice dump by Scotia. 5 cents, here we come.

RE:RE:RE:Nice dump by Scotia. 5 cents, here we come.You know there is a good chance that their vaccine might have propylactic and therapeutic purposes. If that happens,the therapeutic purpose will have a faster testing and potentially might have a faster route of approval because it will be given to sick covid patients.
threefiftynine wrote:
The only way that your scenario comes to fruition is if this trades in the region of of lets say .15 cents in 4 months if this is doing nothing much and just bandwagoned covid (which I doubt) ---BUT lets take a look at another possibility just for talking sake. The PP gets fully closed on or before the next 12 trading days and news gets released that phase1 has been achieved along with funding for PHASE2 --stock value goes , like SONA to over 3 bucks based on the massive exposure this will get with their unusual peptide experimental vaccine . jfyi PHASE2 is the shorter of the 3 phases as human trials are just expanded with more humans ---Costs more money but its a door to PHASE3---what pp and warrant holder in their right mind would sell if they see a company on the verge of corporate greatness---Israel would be doing backflips as would bliggy as he has cashed in at 3 bucks along with some profit taking by pp people and dilution would be the furthest thing on his mind---- "Oh its so nice to be on a board where I don't get trolled every time I post!!! ----or maybe I do" !!!----once infatuated always infatuated I guess---- good luck everyone invested here---its a cr*p shoot that's about to get very interesting I feel


<< Previous
Bullboard Posts
Next >>